JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Johnson & Johnson Enterprise Innovation Inc Clinical trial
Johnson & Johnson Enterprise Innovation Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
191 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medizinische Universitat Graz
Graz, Austria
Completed - Ordensklinikum Linz Gmbh Barmherzige Schwestern
Linz, Austria
Recruiting - Medizinische Universitaet Wien
Vienna, Austria
Recruiting
- Cliniques Universitaires Saint Luc
Brussels, Belgium
Recruiting - Grand Hopital de Charleroi Site Les Viviers
Charleroi, Belgium
Recruiting - Universitair Ziekenhuis Leuven
Leuven, Belgium
Recruiting
- Fundacao Pio Xii - Hospital de Cancer de Barretos
Barretos, Brazil
Recruiting - Nucleo de Ensino E Pesquisa Do Instituto Mario Penna
Belo Horizonte, Brazil
Recruiting - Centro Regional Integrado de Oncologia Crio
Fortaleza, Brazil
Completed - Hospital Haroldo Juaçaba - Instituto Do Câncer Do Ceará
Fortaleza, Brazil
Recruiting - Fundacao Sao Francisco Xavier
Ipatinga, Brazil
Recruiting - Hospital Amaral Carvalho
Jaú, Brazil
Recruiting - Hospital Do Cancer de Londrina
Londrina, Brazil
Recruiting - Hospital Nossa Senhora Da Conceicao
Porto Alegre, Brazil
Completed - Hospital Sao Lucas Da Pucrs
Porto Alegre, Brazil
Recruiting - Irmandade Da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Brazil
Recruiting - Grupo Oncoclinicas - Botafogo
Rio de Janeiro, Brazil
Recruiting - Ensino E Terapia de Inovacao Clinica Amo Etica
Salvador, Brazil
Recruiting - Hospital de Base de Sao Jose Do Rio Preto
São José do Rio Preto, Brazil
Recruiting - Fundacao Faculdade de Medicina - Instituto Do Cancer Do Estado de Sao Paulo
São Paulo, Brazil
Recruiting - Hospital Sirio Libanes Sao Paulo
São Paulo, Brazil
Recruiting - Associacao Feminina de Educacao E Combate Ao Cancer Hospital Santa Rita de Cassia
Vitória, Brazil
Recruiting
- Mhat Uni Hospital
Panagyurishte, Bulgaria
Completed - Specialized Hospital for Active Treatment in Oncology
Sofia, Bulgaria
Completed
- Sunnybrook Health Sciences Center
Toronto, Ontario, Canada
Recruiting
- the Affiliated Hospital of Bengbu Medical College
Bengbu, China
Completed - Hunan Cancer Hospital
Changsha, China
Recruiting - Xiangya Hospital Central South University
Changsha, China
Completed - Sichuan Cancer Hospital
Chengdu, China
Recruiting - Dongguan People S Hospital
Dongguan, China
Recruiting - Fujian Medical University Fujian Provincial Cancer Hospital
Fuzhou, China
Recruiting - Fujian Medical University Union Hospital
Fuzhou, China
Completed - the First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Recruiting - Guangzhou First Municipal People'S Hospital
Guangzhou, China
Recruiting - Guangzhou Medical University Affiliated Oncology Hospital
Guangzhou, China
Recruiting - the First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, China
Recruiting - Qilu Hospital of Shandong University
Jinan, China
Recruiting - Shandong Cancer Hospital
Jinan, China
Recruiting - Linyi Cancer Hospital
Linyi, China
Recruiting - Liuzhou People'S Hospital
Liuzhou, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Dec 2021
- Primary completion
- 30 Jun 2028
- Completion
- 30 Jun 2028
- Last update posted
- 6 Jul 2026
- Registered enrollment
- 500
- Registry id
- NCT04892173
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.